top of page
Laboratory

Common Diseases Profiles

Global Disease Profile

The Center for Research on Common Diseases in Africa and Asia (CEROCDAA) is an Faith-based intercontinental research institute aim to build research infrastructure, human and laboratory capacity, support scientist and researchers to investigate, validate and confirm emerging common diseases in both continent and collaborate with government and institutions and communities to appropriately carry out evidence based public prevention, treatment and social protection measures adequate enough to saves lives and mitigate any impact on communities, individuals and vulnerable populations.

 

According to WHO, new and re-emerging infectious diseases, pose a rising global health threat security over the next 20 years. These emerging diseases may endanger people lives, threaten free movement, and exacerbate social, economic and political instability in affected countries and regions and require community based research preparedness and response efforts by all stakeholders. Globally Infectious diseases are a leading cause of death, accounting for a quarter to a third of the estimated 100 million deaths world-wide.

The spread of infectious diseases results as much from changes in human behavior--including lifestyles and land use patterns, climate change, increased trade and travel, and inappropriate use of antibiotic drugs— for example:

  • Twenty well-known diseases--including tuberculosis (TB), malaria, and cholera--have re-emerged or spread geographically since 1973, often in more virulent and drug-resistant forms.

  • At least 30 previously unknown disease agents have been identified since 1973, including HIV, Ebola, hepatitis C, and Nipah virus, SAS Virus, COVID 19 for which no cures are available.

  • Of the seven biggest killers worldwide, TB, malaria, hepatitis, and HIV/AIDS continue to surge, with HIV/AIDS and TB likely to account for the overwhelming majority of deaths from infectious diseases in developing countries in Africa and Asia by 2020. Acute lower respiratory infections--including pneumonia and influenza--as well as diarrheal diseases and measles, appear to have peaked at high incidence levels.

Vaccine
bottom of page